Matthew Keller
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 44 | 2025 | 1428 | 4.910 |
Why?
| | Polymorphism, Single Nucleotide | 54 | 2025 | 2184 | 4.640 |
Why?
| | Biological Specimen Banks | 7 | 2025 | 102 | 4.180 |
Why?
| | Multifactorial Inheritance | 17 | 2025 | 174 | 3.200 |
Why?
| | Models, Genetic | 23 | 2025 | 599 | 3.160 |
Why?
| | Schizophrenia | 16 | 2022 | 438 | 3.030 |
Why?
| | Genetic Predisposition to Disease | 35 | 2025 | 2412 | 2.900 |
Why?
| | Gene-Environment Interaction | 9 | 2021 | 190 | 1.960 |
Why?
| | Homozygote | 11 | 2023 | 203 | 1.840 |
Why?
| | Genome, Human | 13 | 2021 | 423 | 1.750 |
Why?
| | Genetics, Population | 5 | 2022 | 209 | 1.720 |
Why?
| | Depressive Disorder, Major | 7 | 2022 | 362 | 1.690 |
Why?
| | Phenotype | 32 | 2025 | 3189 | 1.670 |
Why?
| | Genetic Variation | 19 | 2022 | 985 | 1.580 |
Why?
| | Paternal Inheritance | 2 | 2021 | 3 | 1.410 |
Why?
| | Maternal Inheritance | 2 | 2021 | 16 | 1.400 |
Why?
| | Statistics as Topic | 3 | 2021 | 307 | 1.380 |
Why?
| | Dermatology | 3 | 2025 | 126 | 1.310 |
Why?
| | Consanguinity | 4 | 2018 | 49 | 1.240 |
Why?
| | United Kingdom | 9 | 2025 | 310 | 1.180 |
Why?
| | Mental Disorders | 12 | 2022 | 1070 | 1.170 |
Why?
| | Quantitative Trait, Heritable | 8 | 2025 | 125 | 1.150 |
Why?
| | Family | 7 | 2024 | 665 | 1.150 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 809 | 1.130 |
Why?
| | Twins | 5 | 2021 | 242 | 1.120 |
Why?
| | Twins, Dizygotic | 6 | 2013 | 175 | 1.090 |
Why?
| | Humans | 143 | 2025 | 136765 | 1.070 |
Why?
| | Family Characteristics | 2 | 2025 | 189 | 1.070 |
Why?
| | Marriage | 3 | 2025 | 120 | 1.040 |
Why?
| | Genome | 3 | 2018 | 294 | 1.030 |
Why?
| | Cognition | 15 | 2022 | 1146 | 1.030 |
Why?
| | Academic Success | 2 | 2023 | 28 | 1.010 |
Why?
| | Twins, Monozygotic | 5 | 2013 | 203 | 0.980 |
Why?
| | Reproduction | 4 | 2022 | 204 | 0.950 |
Why?
| | Software | 3 | 2017 | 665 | 0.930 |
Why?
| | Smoking | 7 | 2025 | 1620 | 0.910 |
Why?
| | Family Health | 2 | 2024 | 196 | 0.910 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 140 | 0.910 |
Why?
| | Environment | 5 | 2017 | 357 | 0.880 |
Why?
| | Spouses | 1 | 2025 | 105 | 0.880 |
Why?
| | Depression | 4 | 2022 | 1396 | 0.860 |
Why?
| | Sexual Partners | 1 | 2025 | 186 | 0.850 |
Why?
| | Linkage Disequilibrium | 6 | 2025 | 268 | 0.840 |
Why?
| | Genotype | 13 | 2021 | 1914 | 0.820 |
Why?
| | Genetics, Behavioral | 2 | 2020 | 36 | 0.820 |
Why?
| | Body Height | 6 | 2025 | 199 | 0.800 |
Why?
| | Biological Evolution | 4 | 2018 | 467 | 0.790 |
Why?
| | Mentors | 2 | 2025 | 200 | 0.770 |
Why?
| | Intelligence | 6 | 2025 | 123 | 0.760 |
Why?
| | Tobacco Use Disorder | 3 | 2025 | 251 | 0.720 |
Why?
| | Female | 74 | 2025 | 72795 | 0.700 |
Why?
| | Pedigree | 5 | 2024 | 514 | 0.700 |
Why?
| | Haplotypes | 4 | 2018 | 494 | 0.700 |
Why?
| | Computer Simulation | 7 | 2022 | 973 | 0.690 |
Why?
| | Educational Status | 8 | 2024 | 470 | 0.680 |
Why?
| | Inbreeding Depression | 2 | 2021 | 3 | 0.670 |
Why?
| | Male | 63 | 2025 | 67311 | 0.670 |
Why?
| | Algorithms | 3 | 2022 | 1689 | 0.660 |
Why?
| | Research Design | 6 | 2018 | 1127 | 0.630 |
Why?
| | Alleles | 10 | 2024 | 890 | 0.630 |
Why?
| | Twin Studies as Topic | 3 | 2018 | 19 | 0.630 |
Why?
| | Bias | 5 | 2022 | 218 | 0.620 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 605 | 0.600 |
Why?
| | Alcoholism | 6 | 2025 | 804 | 0.600 |
Why?
| | Cervical Length Measurement | 1 | 2018 | 4 | 0.590 |
Why?
| | Adult | 47 | 2025 | 37631 | 0.590 |
Why?
| | Psychological Trauma | 1 | 2019 | 55 | 0.580 |
Why?
| | Genomics | 9 | 2023 | 790 | 0.550 |
Why?
| | Tympanoplasty | 1 | 2017 | 8 | 0.550 |
Why?
| | Tympanic Membrane Perforation | 1 | 2017 | 17 | 0.550 |
Why?
| | Auditory Threshold | 1 | 2017 | 41 | 0.540 |
Why?
| | Blast Injuries | 1 | 2017 | 48 | 0.530 |
Why?
| | Third-Party Consent | 1 | 2016 | 8 | 0.530 |
Why?
| | Beauty | 2 | 2013 | 19 | 0.530 |
Why?
| | Drug Eruptions | 1 | 2016 | 27 | 0.520 |
Why?
| | Proxy | 1 | 2016 | 29 | 0.520 |
Why?
| | Erlotinib Hydrochloride | 1 | 2016 | 72 | 0.520 |
Why?
| | Psychotic Disorders | 2 | 2016 | 169 | 0.510 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 805 | 0.500 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 549 | 0.500 |
Why?
| | Internship and Residency | 2 | 2025 | 1132 | 0.490 |
Why?
| | Genetic Loci | 9 | 2022 | 288 | 0.480 |
Why?
| | Creativity | 1 | 2015 | 16 | 0.480 |
Why?
| | Informed Consent | 1 | 2016 | 172 | 0.480 |
Why?
| | Communication Barriers | 1 | 2016 | 104 | 0.480 |
Why?
| | Nootropic Agents | 3 | 2021 | 27 | 0.470 |
Why?
| | Socioeconomic Factors | 2 | 2019 | 1282 | 0.450 |
Why?
| | Body Mass Index | 5 | 2024 | 2375 | 0.450 |
Why?
| | Likelihood Functions | 5 | 2022 | 143 | 0.440 |
Why?
| | Quantitative Trait Loci | 4 | 2024 | 380 | 0.430 |
Why?
| | Genealogy and Heraldry | 1 | 2013 | 5 | 0.420 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 113 | 0.420 |
Why?
| | Telemedicine | 1 | 2022 | 851 | 0.410 |
Why?
| | Bipolar Disorder | 2 | 2015 | 264 | 0.410 |
Why?
| | Genetic Pleiotropy | 1 | 2013 | 31 | 0.400 |
Why?
| | Wearable Electronic Devices | 2 | 2025 | 53 | 0.400 |
Why?
| | Depressive Disorder | 2 | 2007 | 379 | 0.400 |
Why?
| | Dementia | 1 | 2016 | 256 | 0.400 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 180 | 0.400 |
Why?
| | Middle Aged | 31 | 2025 | 33228 | 0.400 |
Why?
| | Affect | 2 | 2005 | 292 | 0.390 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.380 |
Why?
| | Marijuana Abuse | 1 | 2015 | 232 | 0.370 |
Why?
| | Inbreeding | 1 | 2011 | 18 | 0.370 |
Why?
| | Sex Characteristics | 2 | 2013 | 759 | 0.370 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 304 | 0.360 |
Why?
| | Gene Frequency | 6 | 2022 | 520 | 0.360 |
Why?
| | Adaptation, Psychological | 3 | 2022 | 651 | 0.340 |
Why?
| | Substance-Related Disorders | 5 | 2025 | 1069 | 0.340 |
Why?
| | Risk Factors | 14 | 2025 | 10325 | 0.340 |
Why?
| | Social Environment | 4 | 2019 | 295 | 0.340 |
Why?
| | Genetic Markers | 3 | 2020 | 344 | 0.330 |
Why?
| | Bariatric Surgery | 2 | 2024 | 215 | 0.330 |
Why?
| | Live Birth | 2 | 2020 | 65 | 0.330 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 103 | 0.330 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2009 | 29 | 0.320 |
Why?
| | Uniparental Disomy | 1 | 2009 | 9 | 0.320 |
Why?
| | Models, Statistical | 5 | 2018 | 667 | 0.320 |
Why?
| | Negative-Pressure Wound Therapy | 2 | 2020 | 27 | 0.310 |
Why?
| | Life Change Events | 2 | 2007 | 151 | 0.310 |
Why?
| | Fathers | 1 | 2009 | 50 | 0.310 |
Why?
| | Registries | 2 | 2015 | 2015 | 0.310 |
Why?
| | Stillbirth | 2 | 2019 | 72 | 0.300 |
Why?
| | Personality | 2 | 2012 | 132 | 0.300 |
Why?
| | Aged | 16 | 2025 | 23794 | 0.300 |
Why?
| | Dysphonia | 2 | 2018 | 15 | 0.300 |
Why?
| | Parkinson Disease | 2 | 2025 | 490 | 0.300 |
Why?
| | Models, Theoretical | 3 | 2021 | 575 | 0.300 |
Why?
| | Psychiatry | 1 | 2011 | 180 | 0.300 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2025 | 243 | 0.290 |
Why?
| | Laryngeal Diseases | 2 | 2018 | 31 | 0.290 |
Why?
| | Psoriasis | 2 | 2021 | 102 | 0.290 |
Why?
| | Young Adult | 18 | 2025 | 13127 | 0.290 |
Why?
| | Evolution, Molecular | 2 | 2017 | 488 | 0.290 |
Why?
| | Mendelian Randomization Analysis | 3 | 2024 | 50 | 0.290 |
Why?
| | Parent-Child Relations | 2 | 2021 | 268 | 0.280 |
Why?
| | Genetic Association Studies | 4 | 2019 | 375 | 0.280 |
Why?
| | Inheritance Patterns | 4 | 2021 | 45 | 0.280 |
Why?
| | Adolescent | 26 | 2025 | 21382 | 0.280 |
Why?
| | Myeloproliferative Disorders | 2 | 2019 | 27 | 0.270 |
Why?
| | Chromosomes, Human | 3 | 2018 | 44 | 0.270 |
Why?
| | Retrospective Studies | 16 | 2022 | 15504 | 0.270 |
Why?
| | Computational Biology | 1 | 2011 | 643 | 0.260 |
Why?
| | Pediatric Obesity | 2 | 2024 | 590 | 0.260 |
Why?
| | Neurodevelopmental Disorders | 2 | 2019 | 176 | 0.250 |
Why?
| | Chromosome Mapping | 3 | 2015 | 523 | 0.250 |
Why?
| | Pregnancy | 7 | 2025 | 6726 | 0.250 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3265 | 0.250 |
Why?
| | Selection, Genetic | 2 | 2012 | 264 | 0.240 |
Why?
| | Surveys and Questionnaires | 6 | 2025 | 5742 | 0.240 |
Why?
| | Weather | 1 | 2005 | 40 | 0.240 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2122 | 0.230 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2025 | 51 | 0.230 |
Why?
| | Executive Function | 2 | 2022 | 440 | 0.230 |
Why?
| | Biofeedback, Psychology | 1 | 2025 | 37 | 0.230 |
Why?
| | Tobacco Products | 2 | 2024 | 136 | 0.230 |
Why?
| | Pregnancy Complications | 2 | 2019 | 524 | 0.220 |
Why?
| | Apolipoproteins E | 1 | 2024 | 83 | 0.220 |
Why?
| | Alcohol Drinking | 2 | 2022 | 820 | 0.210 |
Why?
| | Recombination, Genetic | 2 | 2016 | 200 | 0.210 |
Why?
| | Cognition Disorders | 2 | 2019 | 495 | 0.210 |
Why?
| | Deglutition Disorders | 1 | 2025 | 143 | 0.200 |
Why?
| | Parents | 2 | 2022 | 1340 | 0.200 |
Why?
| | Ureteral Calculi | 1 | 2022 | 14 | 0.200 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 9 | 0.200 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2022 | 38 | 0.190 |
Why?
| | Lithotripsy | 1 | 2022 | 48 | 0.190 |
Why?
| | Population Health | 1 | 2023 | 47 | 0.190 |
Why?
| | Face | 2 | 2013 | 173 | 0.190 |
Why?
| | Birth Weight | 1 | 2025 | 514 | 0.190 |
Why?
| | Tobacco Use | 1 | 2022 | 64 | 0.190 |
Why?
| | Health Care Costs | 2 | 2022 | 384 | 0.190 |
Why?
| | Receptors, Nicotinic | 2 | 2025 | 334 | 0.190 |
Why?
| | Faculty, Medical | 1 | 2025 | 283 | 0.190 |
Why?
| | Compartment Syndromes | 1 | 2022 | 25 | 0.190 |
Why?
| | Internationality | 1 | 2022 | 154 | 0.190 |
Why?
| | Fractures, Open | 1 | 2022 | 27 | 0.190 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 413 | 0.190 |
Why?
| | Mutation, Missense | 2 | 2019 | 337 | 0.180 |
Why?
| | Artificial Intelligence | 1 | 2025 | 275 | 0.180 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 21 | 0.180 |
Why?
| | Tibial Fractures | 1 | 2022 | 68 | 0.180 |
Why?
| | Wireless Technology | 1 | 2021 | 13 | 0.180 |
Why?
| | Respiratory Rate | 1 | 2021 | 20 | 0.180 |
Why?
| | Gastric Bypass | 1 | 2022 | 119 | 0.180 |
Why?
| | Tremor | 2 | 2018 | 65 | 0.180 |
Why?
| | Genotyping Techniques | 2 | 2018 | 75 | 0.170 |
Why?
| | Pregnancy, Twin | 1 | 2020 | 19 | 0.170 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 45 | 0.170 |
Why?
| | Inpatients | 2 | 2022 | 496 | 0.170 |
Why?
| | Respiratory Sounds | 1 | 2021 | 125 | 0.170 |
Why?
| | Hospitalization | 5 | 2021 | 2182 | 0.160 |
Why?
| | Hysterectomy | 1 | 2021 | 128 | 0.160 |
Why?
| | Mental Health | 2 | 2024 | 716 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 2020 | 80 | 0.160 |
Why?
| | Medicaid | 2 | 2021 | 433 | 0.160 |
Why?
| | Maternal Health | 1 | 2019 | 49 | 0.160 |
Why?
| | Florida | 4 | 2019 | 103 | 0.160 |
Why?
| | Duffy Blood-Group System | 1 | 2019 | 6 | 0.160 |
Why?
| | History, 21st Century | 1 | 2020 | 212 | 0.160 |
Why?
| | Friends | 1 | 2019 | 52 | 0.160 |
Why?
| | Exotoxins | 1 | 2019 | 16 | 0.160 |
Why?
| | Janus Kinase 2 | 1 | 2019 | 32 | 0.150 |
Why?
| | Orbital Cellulitis | 1 | 2019 | 17 | 0.150 |
Why?
| | Cone Opsins | 1 | 2018 | 2 | 0.150 |
Why?
| | Siblings | 2 | 2013 | 227 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 42 | 0.150 |
Why?
| | Hemolysin Proteins | 1 | 2019 | 34 | 0.150 |
Why?
| | Laryngismus | 1 | 2018 | 9 | 0.150 |
Why?
| | Chronic Pain | 1 | 2023 | 259 | 0.150 |
Why?
| | Dermatitis, Atopic | 1 | 2022 | 329 | 0.150 |
Why?
| | History, 20th Century | 1 | 2020 | 324 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2022 | 259 | 0.150 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2018 | 19 | 0.150 |
Why?
| | Antimicrobial Stewardship | 1 | 2021 | 117 | 0.150 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2019 | 58 | 0.150 |
Why?
| | Time-to-Treatment | 1 | 2020 | 204 | 0.150 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 188 | 0.150 |
Why?
| | Bacterial Toxins | 1 | 2019 | 105 | 0.150 |
Why?
| | Recurrence | 2 | 2019 | 1055 | 0.140 |
Why?
| | Laparoscopy | 1 | 2022 | 464 | 0.140 |
Why?
| | Pregnancy Trimester, Second | 1 | 2018 | 80 | 0.140 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5106 | 0.140 |
Why?
| | Lasers | 1 | 2018 | 130 | 0.140 |
Why?
| | Needs Assessment | 1 | 2020 | 372 | 0.140 |
Why?
| | Europe | 2 | 2022 | 413 | 0.140 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2822 | 0.140 |
Why?
| | Cohort Studies | 6 | 2022 | 5701 | 0.140 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2020 | 177 | 0.140 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 481 | 0.140 |
Why?
| | Neuromuscular Agents | 1 | 2018 | 35 | 0.140 |
Why?
| | Pneumonia, Viral | 1 | 2022 | 368 | 0.140 |
Why?
| | Audiometry, Pure-Tone | 1 | 2017 | 30 | 0.140 |
Why?
| | Botulinum Toxins, Type A | 1 | 2018 | 45 | 0.140 |
Why?
| | Databases, Factual | 4 | 2025 | 1351 | 0.140 |
Why?
| | Mouth | 1 | 2017 | 87 | 0.130 |
Why?
| | Event-Related Potentials, P300 | 1 | 2016 | 14 | 0.130 |
Why?
| | Heart Rate | 1 | 2021 | 820 | 0.130 |
Why?
| | Neurocognitive Disorders | 1 | 2017 | 26 | 0.130 |
Why?
| | Synaptic Transmission | 1 | 2019 | 289 | 0.130 |
Why?
| | Endophenotypes | 1 | 2016 | 21 | 0.130 |
Why?
| | Parenting | 1 | 2020 | 306 | 0.130 |
Why?
| | Phylogeny | 1 | 2021 | 903 | 0.130 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 382 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2017 | 3539 | 0.130 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 155 | 0.130 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 320 | 0.130 |
Why?
| | Patient Discharge | 2 | 2022 | 894 | 0.130 |
Why?
| | Patient Readmission | 1 | 2022 | 694 | 0.130 |
Why?
| | Postpartum Period | 1 | 2019 | 337 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2022 | 780 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 618 | 0.130 |
Why?
| | Retina | 1 | 2018 | 298 | 0.130 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 135 | 0.130 |
Why?
| | Regression Analysis | 3 | 2021 | 1022 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2020 | 539 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 659 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 434 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 182 | 0.120 |
Why?
| | Telephone | 1 | 2016 | 170 | 0.120 |
Why?
| | Pityriasis Rubra Pilaris | 1 | 2015 | 1 | 0.120 |
Why?
| | Curriculum | 1 | 2022 | 975 | 0.120 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2020 | 359 | 0.120 |
Why?
| | Aged, 80 and over | 5 | 2019 | 7585 | 0.120 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 21 | 0.120 |
Why?
| | Guanylate Cyclase | 1 | 2015 | 37 | 0.120 |
Why?
| | Genetic Research | 1 | 2015 | 15 | 0.120 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1935 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2015 | 126 | 0.110 |
Why?
| | United States | 7 | 2025 | 14690 | 0.110 |
Why?
| | Comprehension | 1 | 2016 | 171 | 0.110 |
Why?
| | Staphylococcus aureus | 1 | 2019 | 449 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2019 | 529 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 194 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 399 | 0.110 |
Why?
| | Comorbidity | 2 | 2019 | 1614 | 0.110 |
Why?
| | Masculinity | 1 | 2013 | 9 | 0.110 |
Why?
| | Genetic Fitness | 1 | 2014 | 58 | 0.110 |
Why?
| | Infant, Newborn | 1 | 2025 | 6032 | 0.110 |
Why?
| | Genetic Testing | 1 | 2017 | 453 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2024 | 1163 | 0.110 |
Why?
| | Stress, Psychological | 1 | 2022 | 1097 | 0.110 |
Why?
| | Antisocial Personality Disorder | 1 | 2015 | 168 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2015 | 149 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2019 | 778 | 0.100 |
Why?
| | Africa | 1 | 2013 | 108 | 0.100 |
Why?
| | Interpersonal Relations | 2 | 2008 | 396 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 327 | 0.100 |
Why?
| | Outpatients | 1 | 2016 | 393 | 0.100 |
Why?
| | Biopsy | 1 | 2016 | 1124 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2234 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 916 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2019 | 873 | 0.100 |
Why?
| | Adolescent Development | 1 | 2013 | 86 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2022 | 10745 | 0.100 |
Why?
| | Anxiety Disorders | 1 | 2016 | 374 | 0.100 |
Why?
| | Hematopoietic Stem Cells | 1 | 2015 | 402 | 0.090 |
Why?
| | Choice Behavior | 1 | 2013 | 170 | 0.090 |
Why?
| | Physician-Patient Relations | 1 | 2016 | 548 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 619 | 0.090 |
Why?
| | Parathyroid Glands | 1 | 2011 | 10 | 0.090 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 613 | 0.090 |
Why?
| | Virginia | 2 | 2009 | 62 | 0.090 |
Why?
| | Population Density | 1 | 2011 | 95 | 0.090 |
Why?
| | Life Style | 2 | 2021 | 487 | 0.090 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2011 | 56 | 0.090 |
Why?
| | NF-kappa B | 1 | 2015 | 691 | 0.090 |
Why?
| | Child | 9 | 2024 | 21819 | 0.090 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 168 | 0.090 |
Why?
| | Military Personnel | 1 | 2017 | 544 | 0.080 |
Why?
| | Anthropometry | 2 | 2024 | 213 | 0.080 |
Why?
| | Microbiota | 1 | 2017 | 762 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2013 | 484 | 0.080 |
Why?
| | Decision Making | 1 | 2016 | 898 | 0.080 |
Why?
| | International Classification of Diseases | 2 | 2019 | 132 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 464 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2829 | 0.070 |
Why?
| | Risk | 3 | 2019 | 908 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2016 | 842 | 0.070 |
Why?
| | Prevalence | 1 | 2015 | 2710 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2009 | 237 | 0.070 |
Why?
| | Thinking | 1 | 2008 | 65 | 0.070 |
Why?
| | Personality Inventory | 1 | 2007 | 140 | 0.070 |
Why?
| | Health Status | 2 | 2024 | 788 | 0.070 |
Why?
| | Incidence | 2 | 2025 | 2792 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2011 | 752 | 0.070 |
Why?
| | Analysis of Variance | 3 | 2018 | 1316 | 0.060 |
Why?
| | Diseases in Twins | 1 | 2007 | 169 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1167 | 0.060 |
Why?
| | Gestational Age | 2 | 2019 | 902 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1261 | 0.060 |
Why?
| | Length of Stay | 2 | 2022 | 1205 | 0.060 |
Why?
| | Personality Assessment | 1 | 2005 | 84 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2006 | 64 | 0.060 |
Why?
| | Transcriptome | 2 | 2022 | 969 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2605 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 547 | 0.060 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2046 | 0.060 |
Why?
| | Ectodermal Dysplasia | 1 | 2005 | 19 | 0.060 |
Why?
| | Norway | 1 | 2024 | 43 | 0.060 |
Why?
| | Connexin 43 | 1 | 2005 | 31 | 0.060 |
Why?
| | Connexins | 1 | 2005 | 48 | 0.060 |
Why?
| | Social Isolation | 1 | 2005 | 61 | 0.060 |
Why?
| | Australia | 1 | 2005 | 313 | 0.060 |
Why?
| | Mastectomy | 1 | 2025 | 136 | 0.060 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 17 | 0.050 |
Why?
| | Mammaplasty | 1 | 2025 | 105 | 0.050 |
Why?
| | Child, Preschool | 4 | 2020 | 10997 | 0.050 |
Why?
| | Ureteroscopy | 1 | 2022 | 18 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 267 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 125 | 0.050 |
Why?
| | Social Behavior | 2 | 2019 | 284 | 0.050 |
Why?
| | Pruritus | 1 | 2022 | 63 | 0.050 |
Why?
| | Paralysis | 1 | 2022 | 70 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2024 | 245 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2025 | 595 | 0.050 |
Why?
| | Upper Extremity | 1 | 2022 | 99 | 0.050 |
Why?
| | Hand | 1 | 2022 | 155 | 0.040 |
Why?
| | Infant | 3 | 2020 | 9395 | 0.040 |
Why?
| | Brain | 3 | 2023 | 2664 | 0.040 |
Why?
| | Tibia | 1 | 2022 | 178 | 0.040 |
Why?
| | Gene Expression | 1 | 2006 | 1500 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 339 | 0.040 |
Why?
| | Animals | 6 | 2019 | 36847 | 0.040 |
Why?
| | Inappropriate Prescribing | 1 | 2021 | 55 | 0.040 |
Why?
| | Bone Density | 1 | 2024 | 487 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 3946 | 0.040 |
Why?
| | Social Sciences | 1 | 2019 | 8 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 985 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1692 | 0.040 |
Why?
| | Nebraska | 1 | 2019 | 18 | 0.040 |
Why?
| | Arkansas | 1 | 2019 | 17 | 0.040 |
Why?
| | Iowa | 1 | 2019 | 30 | 0.040 |
Why?
| | Receptors, Thrombopoietin | 1 | 2019 | 6 | 0.040 |
Why?
| | Maryland | 1 | 2019 | 59 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 267 | 0.040 |
Why?
| | Wisconsin | 1 | 2019 | 100 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2104 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 29 | 0.040 |
Why?
| | New York | 1 | 2019 | 126 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 36 | 0.040 |
Why?
| | Infrared Rays | 1 | 2018 | 25 | 0.040 |
Why?
| | Macaca fascicularis | 1 | 2018 | 65 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2019 | 91 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 44 | 0.040 |
Why?
| | Biometry | 1 | 2018 | 70 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 518 | 0.040 |
Why?
| | Morbidity | 1 | 2019 | 323 | 0.040 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 67 | 0.040 |
Why?
| | Laryngeal Muscles | 1 | 2018 | 12 | 0.040 |
Why?
| | Voice Quality | 1 | 2018 | 22 | 0.040 |
Why?
| | Cefotaxime | 1 | 2017 | 2 | 0.040 |
Why?
| | Counseling | 1 | 2021 | 388 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2024 | 558 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 306 | 0.040 |
Why?
| | Age Distribution | 1 | 2018 | 389 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 126 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 373 | 0.030 |
Why?
| | Peer Group | 1 | 2019 | 241 | 0.030 |
Why?
| | Hospitals | 1 | 2022 | 684 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 530 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1006 | 0.030 |
Why?
| | Contactins | 1 | 2016 | 2 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 776 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 412 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 1065 | 0.030 |
Why?
| | Saccades | 1 | 2016 | 40 | 0.030 |
Why?
| | Reaction Time | 1 | 2018 | 412 | 0.030 |
Why?
| | Linear Models | 2 | 2012 | 846 | 0.030 |
Why?
| | Mice | 3 | 2019 | 17757 | 0.030 |
Why?
| | Mothers | 1 | 2022 | 752 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5423 | 0.030 |
Why?
| | Alcohol Abstinence | 1 | 2015 | 12 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1321 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 362 | 0.030 |
Why?
| | Cell Survival | 1 | 2019 | 1116 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2016 | 183 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1458 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1507 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 283 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 992 | 0.030 |
Why?
| | Finland | 1 | 2014 | 85 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 101 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2067 | 0.030 |
Why?
| | Genetic Phenomena | 1 | 2013 | 8 | 0.030 |
Why?
| | Electroencephalography | 1 | 2016 | 430 | 0.030 |
Why?
| | Synapses | 1 | 2017 | 427 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 59 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2060 | 0.030 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 62 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 378 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2015 | 201 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1301 | 0.020 |
Why?
| | Risk-Taking | 1 | 2015 | 347 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 97 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3008 | 0.020 |
Why?
| | Parathyroidectomy | 1 | 2011 | 9 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3284 | 0.020 |
Why?
| | Chromatin | 1 | 2015 | 519 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1773 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 36 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4191 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3405 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4013 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3432 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2011 | 106 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1797 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1094 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2022 | 2639 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4515 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 98 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 258 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 243 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4144 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6808 | 0.020 |
Why?
| | Trachea | 1 | 2011 | 237 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4062 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1022 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1044 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4282 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 1982 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2011 | 630 | 0.020 |
Why?
| | Connexin 26 | 1 | 2005 | 8 | 0.010 |
Why?
| | Roma | 1 | 2005 | 2 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 79 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2005 | 115 | 0.010 |
Why?
| | Data Collection | 1 | 2008 | 668 | 0.010 |
Why?
| | Motor Cortex | 1 | 2005 | 65 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2008 | 772 | 0.010 |
Why?
| | Functional Laterality | 1 | 2005 | 223 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 399 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2005 | 309 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1059 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5076 | 0.010 |
Why?
| | Pain | 1 | 2005 | 754 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3555 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|